Xenon Pharmaceuticals Inc. (XENE): Biotechnology Value Fund Adds More Shares

Page 3 of 10

Page 3 of 10 – SEC Filing

1
NAME OF REPORTING PERSON
BVF Partners L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a) x
  (b) o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
0 shares
6
SHARED VOTING POWER
3,108,905
7
SOLE DISPOSITIVE POWER
0 shares
8
SHARED DISPOSITIVE POWER
3,108,905
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,108,905
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
¨
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
17.9%
12
TYPE OF REPORTING PERSON
 
PN, IA

Follow Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Page 3 of 10